Comparing the Efficacy, Safety, and Tolerability of Rabeprazole ER 50 mg With Placebo in Subjects With Symptomatic Gastroesophageal Reflux Disease (sGERD)

Name: Comparing the Efficacy, Safety, and Tolerability of Rabeprazole ER 50 mg With Placebo in Subjects With Symptomatic Gastroesophageal Reflux Disease (sGERD)
Published: 2009
License: Public Domain

Eisai Inc. · 2009

ClinicalTrials.gov · Datasets · License: Public Domain · 2009

Open Source ↗

gastroesophageal-reflux-disease

symptomatic gastroesophageal reflux disease (sgerd), gastroesophageal reflux disease, gerd, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Comparing the Efficacy, Safety, and Tolerability of Rabeprazole ER 50 mg With Placebo in Subjects With Symptomatic Gastroesophageal Reflux Disease (sGERD)

Related documents